These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 10706126)

  • 1. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice.
    Hassan AB; Howell JA
    Cancer Res; 2000 Feb; 60(4):1070-6. PubMed ID: 10706126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble IGF2 receptor rescues Apc(Min/+) intestinal adenoma progression induced by Igf2 loss of imprinting.
    Harper J; Burns JL; Foulstone EJ; Pignatelli M; Zaina S; Hassan AB
    Cancer Res; 2006 Feb; 66(4):1940-8. PubMed ID: 16488992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
    Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
    Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin, insulin-like growth factor-1, and insulin-like growth factor-2 are mitogens in ApcMin/+ but not Apc+/+ colonic epithelial cell lines.
    Fenton JI; Hord NG; Lavigne JA; Perkins SN; Hursting SD
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1646-52. PubMed ID: 16030096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K; Baudino TA
    Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk.
    Kaneda A; Feinberg AP
    Cancer Res; 2005 Dec; 65(24):11236-40. PubMed ID: 16357124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
    Watson SA; Smith AM
    Cancer Res; 2001 Jan; 61(2):625-31. PubMed ID: 11212260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of the maternally imprinted IGF2 allele in TGFalpha induced hepatocellular carcinomas in mice.
    Harris TM; Rogler LE; Rogler CE
    Oncogene; 1998 Jan; 16(2):203-9. PubMed ID: 9464538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.
    Dove WF; Cormier RT; Gould KA; Halberg RB; Merritt AJ; Newton MA; Shoemaker AR
    Philos Trans R Soc Lond B Biol Sci; 1998 Jun; 353(1370):915-23. PubMed ID: 9684289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis.
    Li M; Edamatsu H; Kitazawa R; Kitazawa S; Kataoka T
    Carcinogenesis; 2009 Aug; 30(8):1424-32. PubMed ID: 19458037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
    Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
    Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.
    Dubé PE; Forse CL; Bahrami J; Brubaker PL
    Gastroenterology; 2006 Aug; 131(2):589-605. PubMed ID: 16890611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice.
    Barone M; Tanzi S; Lofano K; Scavo MP; Pricci M; Demarinis L; Papagni S; Guido R; Maiorano E; Ingravallo G; Comelli MC; Francavilla A; Di Leo A
    Carcinogenesis; 2010 Feb; 31(2):269-74. PubMed ID: 19945967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth stimulation of intestinal tumours in Apc(Min/+) mice by dietary L-methionine supplementation.
    Paulsen JE; Alexander J
    Anticancer Res; 2001; 21(5):3281-4. PubMed ID: 11848484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
    Lee J; Hargest R; Wasan H; Phillips RK
    Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APC in the regulation of intestinal crypt fission.
    Wasan HS; Park HS; Liu KC; Mandir NK; Winnett A; Sasieni P; Bodmer WF; Goodlad RA; Wright NA
    J Pathol; 1998 Jul; 185(3):246-55. PubMed ID: 9771477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.
    Kettunen HL; Kettunen AS; Rautonen NE
    Cancer Res; 2003 Aug; 63(16):5136-42. PubMed ID: 12941845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary carbohydrate source alters gene expression profile of intestinal epithelium in mice.
    Wang B; Bobe G; LaPres JJ; Bourquin LD
    Nutr Cancer; 2009; 61(1):146-55. PubMed ID: 19116885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.